What is Teladoc Health's 2030 and thereafter?

Teladoc Health (TDOC) reported 2030 and thereafter of $472.63M in Q1 2026.

How has Teladoc Health's 2030 and thereafter changed year-over-year?

Teladoc Health's 2030 and thereafter decreased by 17.9% year-over-year, from $575.68M to $472.63M.

Teladoc Health TDOC 2030 and thereafter

Other financials

Income statement

See full

Revenue$613.8M-2.5%

Gross profit$416.3M-3.8%

Operating income-$61.8M+48.8%

Net income-$63.8M+31.4%

EPS (diluted)-$0.36+32.1%

Balance sheet

See full

Cash & equivalents$750.7M-37.1%

Total debt$42.2M-92.9%

Total equity$1.3B-6.4%

Total assets$2.8B-18.5%

Cash flow

See full

Operating cash flow$9.5M-40.2%

CapEx$1.7M-39.1%

Free cash flow$7.9M-40.5%

Valuation

See full

Market cap$1.41B+16.5%

Enterprise value$701.31M+14.7%

P/S0.6×+0.1×

Profitability

See full

Gross margin69.3%-1.2pp

Operating margin-8.1%-3.6pp

Net margin-6.8%-3.1pp

FCF margin11.1%-0.2pp

Returns & leverage

See full

Return on equity-12.4%-5.4pp

Debt / equity0×-0.4×

Current ratio2.8×+1.1×

Where this comes from

Reported directly by Teladoc Health in its filing.

Tagged under the XBRL concept tdoc:FiniteLivedIntangibleAssetExpectedAmortizationYearFourAndThereafter.

The official record: Teladoc Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teladoc Health's 2030 and thereafter.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Teladoc Health's 2030 and thereafter?: Teladoc Health (TDOC) reported 2030 and thereafter of $472.63M in Q1 2026.
How has Teladoc Health's 2030 and thereafter changed year-over-year?: Teladoc Health's 2030 and thereafter decreased by 17.9% year-over-year, from $575.68M to $472.63M.